139 related articles for article (PubMed ID: 12584679)
1. Use of a C6 ELISA test to evaluate the efficacy of a whole-cell bacterin for the prevention of naturally transmitted canine Borrelia burgdorferi infection.
Levy SA
Vet Ther; 2002; 3(4):420-4. PubMed ID: 12584679
[TBL] [Abstract][Full Text] [Related]
2. Multiple antigen target approach using the Accuplex4 BioCD system to detect Borrelia burgdorferi antibodies in experimentally infected and vaccinated dogs.
Moroff S; Woodruff C; Woodring T; Sokolchik I; Lappin MR
J Vet Diagn Invest; 2015 Sep; 27(5):581-8. PubMed ID: 26289718
[TBL] [Abstract][Full Text] [Related]
3. Utility of an in-office C6 ELISA test kit for determination of infection status of dogs naturally exposed to Borrelia burgdorferi.
Levy S; O'Connor TP; Hanscom JL; Shields P
Vet Ther; 2002; 3(3):308-15. PubMed ID: 12447839
[TBL] [Abstract][Full Text] [Related]
4. Immunization with a recombinant subunit OspA vaccine markedly impacts the rate of newly acquired Borrelia burgdorferi infections in client-owned dogs living in a coastal community in Maine, USA.
Eschner AK; Mugnai K
Parasit Vectors; 2015 Feb; 8():92. PubMed ID: 25890386
[TBL] [Abstract][Full Text] [Related]
5. Performance of a Borrelia burgdorferi bacterin in borreliosis-endemic areas.
Levy SA; Lissman BA; Ficke CM
J Am Vet Med Assoc; 1993 Jun; 202(11):1834-8. PubMed ID: 8320151
[TBL] [Abstract][Full Text] [Related]
6. Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.
LaFleur RL; Dant JC; Wasmoen TL; Callister SM; Jobe DA; Lovrich SD; Warner TF; Abdelmagid O; Schell RF
Clin Vaccine Immunol; 2009 Feb; 16(2):253-9. PubMed ID: 19052162
[TBL] [Abstract][Full Text] [Related]
7. Borrelia burgdorferi Antibody Test Results in Dogs Administered 4 Different Vaccines.
Stillman BA; Thatcher B; Beall MJ; Lappin M; O'Connor TP; Chandrashekar R
Top Companion Anim Med; 2019 Dec; 37():100358. PubMed ID: 31837754
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a canine C6 ELISA Lyme disease test for the determination of the infection status of cats naturally exposed to Borrelia burgdorferi.
Levy SA; O'Connor TP; Hanscom JL; Shields P
Vet Ther; 2003; 4(2):172-7. PubMed ID: 14506593
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of the ability of a canine Lyme vaccine to reduce the incidence of histological synovial lesions following experimentally-induced canine Lyme borreliosis.
Grosenbaugh DA; Rissi DR; Krimer PM
Vet Immunol Immunopathol; 2016 Nov; 180():29-33. PubMed ID: 27692092
[TBL] [Abstract][Full Text] [Related]
10. Detection of antibodies to decorin-binding protein A (DbpA) and DbpB after infection of dogs with
Oldenburg DG; Jobe DA; Lovrich SD; LaFleur RL; White DW; Dant JC; Callister SM
J Vet Diagn Invest; 2020 May; 32(3):481-485. PubMed ID: 32194000
[TBL] [Abstract][Full Text] [Related]
11. Reactivity of dog sera to whole-cell or recombinant antigens of Borrelia burgdorferi by ELISA and immunoblot analysis.
Magnarelli LA; Levy SA; Ijdo JW; Wu C; Padula SJ; Fikrig E
J Med Microbiol; 2001 Oct; 50(10):889-895. PubMed ID: 11599738
[TBL] [Abstract][Full Text] [Related]
12. Dogs vaccinated with common Lyme disease vaccines do not respond to IR6, the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi.
O'Connor TP; Esty KJ; Hanscom JL; Shields P; Philipp MT
Clin Diagn Lab Immunol; 2004 May; 11(3):458-62. PubMed ID: 15138170
[TBL] [Abstract][Full Text] [Related]
13. One-year duration of immunity induced by vaccination with a canine Lyme disease bacterin.
LaFleur RL; Callister SM; Dant JC; Jobe DA; Lovrich SD; Warner TF; Wasmoen TL; Schell RF
Clin Vaccine Immunol; 2010 May; 17(5):870-4. PubMed ID: 20237200
[TBL] [Abstract][Full Text] [Related]
14. A fluorescent bead-based multiplex assay for the simultaneous detection of antibodies to B. burgdorferi outer surface proteins in canine serum.
Wagner B; Freer H; Rollins A; Erb HN
Vet Immunol Immunopathol; 2011 Apr; 140(3-4):190-8. PubMed ID: 21208663
[TBL] [Abstract][Full Text] [Related]
15. Protection against tick-transmitted Lyme disease in dogs vaccinated with a multiantigenic vaccine.
Straubinger RK; Dharma Rao T; Davidson E; Summers BA; Jacobson RH; Frey AB
Vaccine; 2001 Oct; 20(1-2):181-93. PubMed ID: 11567763
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a nonadjuvanted, outer surface protein A, recombinant vaccine in dogs after challenge by ticks naturally infected with Borrelia burgdorferi.
Conlon JA; Mather TN; Tanner P; Gallo G; Jacobson RH
Vet Ther; 2000; 1(2):96-107. PubMed ID: 19757556
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to Borrelia burgdorferi OspA, OspC, OspF, and C6 antigens as markers for early and late infection in dogs.
Wagner B; Freer H; Rollins A; Garcia-Tapia D; Erb HN; Earnhart C; Marconi R; Meeus P
Clin Vaccine Immunol; 2012 Apr; 19(4):527-35. PubMed ID: 22336289
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and efficacy study of a commercial Borrelia burgdorferi bacterin.
Chu HJ; Chavez LG; Blumer BM; Sebring RW; Wasmoen TL; Acree WM
J Am Vet Med Assoc; 1992 Aug; 201(3):403-11. PubMed ID: 1506244
[TBL] [Abstract][Full Text] [Related]
19. Quantitative approach for the serodiagnosis of canine Lyme disease by the immunoblot procedure.
Guerra MA; Walker ED; Kitron U
J Clin Microbiol; 2000 Jul; 38(7):2628-32. PubMed ID: 10878054
[TBL] [Abstract][Full Text] [Related]
20. Vaccination of horses with Lyme vaccines for dogs induces short-lasting antibody responses.
Guarino C; Asbie S; Rohde J; Glaser A; Wagner B
Vaccine; 2017 Jul; 35(33):4140-4147. PubMed ID: 28668566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
